InsidersTradesSigma
Total declarations
Companies
▲ Purchases (90 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
90
Disclosed sells
0
T+90 hit rate
53%
T+90 mean return
+82.9%
Across 30 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Gagnon Neil, Executive. Officer active across 5 companies, notably Apollo Endosurgery, Inc.. Aggregated, 94 disclosures have been recorded. Breakdown: 90 buys · 0 sell. Total volume traded: €2.9m. Activity tracked since 21 May 2021. The latest transaction was disclosed on 3 June 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations94 total
3,338 shares@ US$5.85120.7% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000191:0
Ideal exit: 28 Feb 2025 (T+270)
1,313 shares@ US$6.28150.3% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000174:0
Ideal exit: 7 Feb 2025 (T+270)
48,683 shares@ US$2.0028.2% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000153:0
Ideal exit: 25 Jan 2025 (T+270)
1,181 shares@ US$2.000.7% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000149:0
Ideal exit: 20 Dec 2024 (T+270)
2,354 shares@ US$5.98530.5% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000147:0
Ideal exit: 18 Jan 2025 (T+270)
1,321 shares@ US$2.000.8% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000134:0
Ideal exit: 17 Dec 2024 (T+270)
5,392 shares@ US$2.003.1% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000132:0
Ideal exit: 15 Dec 2024 (T+270)
5,000 shares@ US$2.002.9% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000128:0
Ideal exit: 26 Nov 2024 (T+270)
25,069 shares@ US$1.949313.9% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000116:0
Ideal exit: 25 Nov 2024 (T+270)
976 shares@ US$2.000.6% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000103:0
Ideal exit: 16 Nov 2024 (T+270)
5,731 shares@ US$6.71981.4% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000091:0
Ideal exit: 9 Nov 2024 (T+270)
631 shares@ US$2.000.4% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000067:0
Ideal exit: 5 Nov 2024 (T+270)
1,169 shares@ US$6.79690.3% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000068:0
Ideal exit: 8 Nov 2024 (T+270)
55 shares@ US$6.800.0% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000047:0
Ideal exit: 28 Oct 2024 (T+270)
5,000 shares@ US$6.79671.2% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000045:0
Ideal exit: 26 Oct 2024 (T+270)
348 shares@ US$1.87180.2% of flowCommon Stock, par value $0.001 per shareSEC:0001019056-24-000037:0
Ideal exit: 20 Oct 2024 (T+270)
1,900 shares@ US$6.54940.4% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000020:0
Ideal exit: 6 Oct 2024 (T+270)
6,694 shares@ US$6.33541.5% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-24-000017:0
Ideal exit: 4 Oct 2024 (T+270)
636 shares@ US$7.44650.2% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000313:0
Ideal exit: 12 Apr 2024 (T+270)
3,126 shares@ US$6.9870.8% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000306:0
Ideal exit: 2 Apr 2024 (T+270)
6,725 shares@ US$6.83531.7% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000304:0
Ideal exit: 1 Apr 2024 (T+270)
5,107 shares@ US$6.99171.3% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000297:0
Ideal exit: 23 Mar 2024 (T+270)
2,062 shares@ US$6.99850.5% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000293:0
Ideal exit: 22 Mar 2024 (T+270)
3,670 shares@ US$6.850.9% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000282:0
Ideal exit: 17 Mar 2024 (T+270)
1,676 shares@ US$6.79860.4% of flowCommon Stock, $0.01 par value per shareSEC:0001019056-23-000272:0
Ideal exit: 8 Mar 2024 (T+270)
25 of 94 declarations
About Gagnon Neil
Neil Gagnon is an executive involved in several companies, including Apollo Endosurgery, Inc., SecureWorks Corp, and Power Solutions International, Inc. His role places him at the heart of the strategy and management of these companies. Neil brings diverse expertise and a strategic vision, contributing to the direction and performance of the organizations.
